Core Viewpoint - Jiangsu Haobo Biopharmaceutical Co., Ltd. has been established with a registered capital of 200 million RMB, fully owned by Jiangsu Kangyuan Pharmaceutical Co., Ltd. [1] Company Overview - Company Name: Jiangsu Haobo Biopharmaceutical Co., Ltd. [1] - Legal Representative: Xiao Lihao [1] - Registered Capital: 200 million RMB [1] - Shareholder: Jiangsu Kangyuan Pharmaceutical Co., Ltd. holds 100% [1] - Business Scope: Includes drug production, drug wholesale (subject to approval), technical services, technology development, consulting, marketing planning, and enterprise management consulting [1] Industry Classification - National Standard Industry: Scientific research and technical service industry, technology promotion and application service industry, technical promotion services [1] - Business Address: Changzhou Xitaihu Technology Industrial Park, Longyang Road, Building F3, 3rd Floor [1] - Company Type: Limited liability company (wholly owned by a natural person) [1] - Business Duration: Until January 23, 2026, with no fixed term thereafter [1] - Registration Authority: Changzhou Wujin District Administrative Service Management Office [1]
江苏皓博生物医药有限公司成立,注册资本20000万人民币